Cue Biopharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $2,149 | $2,954 | $421 | $1,576 |
Gross Profit | 2,069 | 2,954 | 421 | 1,576 |
EBITDA | -7,294 | -7,641 | -11,247 | -9,245 |
EBIT | -7,373 | -8,437 | -12,129 | -9,343 |
Net Income | -7,448 | -8,482 | -12,257 | -9,496 |
Net Change In Cash | 2,149 | 2,954 | 421 | 1,576 |
Free Cash Flow | -9,024 | -3,442 | -8,322 | -9,030 |
Cash | 11,701 | 27,492 | 13,136 | 22,459 |
Basic Shares | 100,869 | 95,459 | 74,254 | 74,238 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $9,287 | $5,490 | $1,245 | $14,941 |
Gross Profit | 9,287 | -32,607 | 1,245 | 14,941 |
EBITDA | -37,528 | -46,052 | -50,491 | -45,490 |
EBIT | -39,878 | -49,488 | -52,297 | -43,712 |
Net Income | -40,674 | -50,733 | -53,010 | -44,161 |
Net Change In Cash | 9,287 | 5,490 | 1,245 | 14,941 |
Cost of Revenue | -12,756 | -10,495 | ||
Free Cash Flow | -36,395 | -39,961 | -41,977 | -39,750 |
Cash | 22,459 | 48,514 | 51,614 | 64,370 |
Basic Shares | 56,328 | 45,754 | 35,649 | 31,285 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.07 |
2025-06-30 | -$0.09 |
2025-03-31 | -$0.12 |
